Effectiveness of Testofen Compared to Placebo on Long COVID Symptoms
Status:
Not yet recruiting
Trial end date:
2025-08-01
Target enrollment:
Participant gender:
Summary
This is a double blind, randomised, placebo-controlled trial to evaluate orally-dosed
Testofen (a specialised extract of Trigonella foenum-graecum (Fenugreek) seed) compared to
placebo on post COVID-19 symptoms in otherwise healthy participants 18 years and over.